Results 161 to 170 of about 9,939 (212)

Normal tissue complication probability modeling of severe radiation-induced lymphopenia using blood dose for lung cancer patients treated with IMRT and IMPT. [PDF]

Front Immunol
Wang S, Dai T, Fan X, Li W, Huang W, Wang R, Yin Y.   +6 more
europepmc   +1 more source

Tumor shrinkage after simultaneous proton therapy for multiple hepatocellular carcinomas. [PDF]

J Radiat Res
Niitsu H, Mizumoto M, Li Y, Sumiya T, Baba K, Murakami M, Nakamura M, Ishida T, Iizumi T, Saito T, Numajiri H, Makishima H, Nakai K, Oshiro Y, Sakurai H.   +14 more
europepmc   +1 more source

Assessment of Tumor Relative Biological Effectiveness in Low-LET Proton Irradiation. [PDF]

Biomedicines
Lin YC, Mo J, Lee YH.
europepmc   +1 more source

Cumulative Dose Analysis in Adaptive Carbon Ion Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer. [PDF]

Cancers (Basel)
Ju Z, Sakai M, Meng X, Kubo N, Kawamura H, Ohno T.   +5 more
europepmc   +1 more source

The Estimated Difference in Biologically Effective Dose Between Two-Opposing-Fields-Per-Day and One-Alternating-Field-Per-Day Carbon Ion Radiation Therapy for Prostate Cancer. [PDF]

Adv Radiat Oncol
Chiou CC, Liu YM, Lan KL, Wu YH, Lai TY, Kang YM, Chen JP, Hu YW.   +7 more
europepmc   +1 more source

Novel Physical and Biological Applications of Carbon Ion Radiotherapy. [PDF]

Cancers (Basel)
Seneviratne D, Biswal P, Krishnan S.
europepmc   +1 more source

Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma. [PDF]

Int Cancer Conf J
Anzai H, Miwa C, Ogasawara S, Fujiya M, Kurosaki H, Tsuchiya T, Yoshino R, Katayama K, Sawada M, Akatsuka T, Izai R, Yonemoto T, Yumita S, Koroki K, Inoue M, Nakamura M, Kanogawa N, Nakamoto S, Makishima H, Shinoto M, Wakatsuki M, Yamada S, Ishikawa H, Kato J.   +23 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Relative biological effectiveness (RBE) values for proton beam therapy

International Journal of Radiation Oncology*Biology*Physics, 2002
Clinical proton beam therapy has been based on the use of a generic relative biological effectiveness (RBE) of 1.0 or 1.1, since the available evidence has been interpreted as indicating that the magnitude of RBE variation with treatment parameters is small relative to our abilities to determine RBEs.
Harald, Paganetti, Andrzej, Niemierko, Marek, Ancukiewicz, Leo E, Gerweck, Michael, Goitein, Jay S, Loeffler, Herman D, Suit   +6 more
openaire   +4 more sources